Livestock Improvement Corporation Ltd

LIC maintains a strong liquidity position with a current ratio of 3.29 and cash and equivalents of NZD 57.1 million, which is well above the industry median for liquidity coverage. The company's liquidity FPT (free cash flow to total liabilities) is robust, indicating a solid ability to meet short-term obligations without external financing. Profitability metrics show that LIC generates a return on equity (ROE) of 10.27% and a return on assets (ROA) of 7.82%, both of which are above the industry median for agri-tech firms. The company's operating margin of 13.34% (calculated from operating income of NZD 39.35 million on revenue of NZD 295.11 million) is also strong, reflecting efficient cost management and pricing power in its core markets. LIC's revenue is distributed across four segments: NZ market genetics (58% of revenue), Herd testing (19%), Farm software (12%), and International (11%). The company's geographic exposure is primarily concentrated in New Zealand, with the international segment serving as a growth lever. The NZ market genetics segment is the most significant contributor to revenue, underscoring the company's domestic focus. Looking ahead, LIC is projected to grow revenue by 4.2% in the current fiscal year and 3.8% in the next, driven by continued demand for genetic improvement and digital farm management tools. The company's capital expenditure of NZD 27.81 million in the latest period reflects ongoing investment in technology and infrastructure to support this growth. Risk factors for LIC include exposure to agricultural commodity price volatility and regulatory changes in the agri-tech sector. However, the company's low debt-to-equity ratio of 0.08 and strong free cash flow position it well to manage these risks. No immediate dilution or liquidity flags were detected in the latest filings, and the company's dilution potential remains low. Recent events include the continued expansion of the MINDA herd management system and the introduction of new genetic products in the international market. These developments are expected to drive long-term value creation and support the company's growth trajectory.